You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

FLUORESCITE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fluorescite, and when can generic versions of Fluorescite launch?

Fluorescite is a drug marketed by Alcon Labs Inc and is included in one NDA.

The generic ingredient in FLUORESCITE is fluorescein sodium. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fluorescein sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fluorescite

A generic version of FLUORESCITE was approved as fluorescein sodium by NEXUS PHARMS on September 25th, 2023.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FLUORESCITE?
  • What are the global sales for FLUORESCITE?
  • What is Average Wholesale Price for FLUORESCITE?
Summary for FLUORESCITE
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 43
Clinical Trials: 10
Patent Applications: 628
What excipients (inactive ingredients) are in FLUORESCITE?FLUORESCITE excipients list
DailyMed Link:FLUORESCITE at DailyMed
Drug patent expirations by year for FLUORESCITE
Recent Clinical Trials for FLUORESCITE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Aditya KazaPhase 2
National Heart, Lung, and Blood Institute (NHLBI)Phase 2
UpTru Inc.Phase 1

See all FLUORESCITE clinical trials

Pharmacology for FLUORESCITE
Drug ClassDiagnostic Dye
Mechanism of ActionDyes

US Patents and Regulatory Information for FLUORESCITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Labs Inc FLUORESCITE fluorescein sodium INJECTABLE;INTRAVENOUS 021980-001 Mar 28, 2006 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.